Search Results 151-160 of 20853 for ulcerative colitis

1. An Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis - Mayo Clinic

   The purpose of the trial is to determine the safety and efficacy of RPC1063 in patients diagnosed with moderate to severe ulcerative colitis. Participation ...

2. Pharmacokinetics and Pharmacodynamic Biomarkers of Janus Kinase Inhibitor Therapy in Patients with Ulcerative Colitis (PROPHETIC Study) - Mayo Clinic

   Pharmacokinetics and Pharmacodynamic Biomarkers of Janus Kinase Inhibitor Therapy in Patients with Ulcerative Colitis (PROPHETIC Study) · Overview · Participation ...

3. A Study to Evaluate the Safety, Effectiveness and Microbiological Response of Orally Administered ABI-M201 in Subjects with Mildly-to-Moderately Active Ulcerative Colitis with Ongoing Mesalamine Treatment - Mayo Clinic

   To evaluate a new oral treatment, ABI-M201 (or placebo) in individuals with mild to moderate Ulcerative Colitis who have sustained an inadequate response to ...

4. Mayo Clinic Q and A: Treating inflammatory bowel disease

   It is not possible to tell from your question what kind of inflammatory bowel disease you have (ulcerative colitis or Crohn's disease). As the types of surgery ...

5. A Study of the Long-Term Safety and Effectiveness of Adalimumab for Repeat Treatment of Pediatric Patients with Ulcerative Colitis - Mayo Clinic

   A Study of the Long-Term Safety and Effectiveness of Adalimumab for Repeat Treatment of Pediatric Patients with Ulcerative Colitis.

6. A Study to Evaluate the Patterns of Use of Biological Agents and Risk Factors for Discontinuation of Agents in Pediatric Crohn’s Disease (CD) and Ulcerative Colitis (UC) within the Pediatric Population - Mayo Clinic

   ... Ulcerative Colitis (UC) within the Pediatric Population. Print details. Share ... ulcerative colitis (UC) within the ICN network. This will be a ...

7. Proctitis - Diagnosis & treatment - Mayo Clinic

   Proctitis caused by inflammatory bowel disease. Treatment of proctitis related to ulcerative colitis or Crohn's disease focuses on reducing inflammation in the ...

8. A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis - Mayo Clinic

   ... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview.

9. Expert explains how inflammatory bowel disease, irritable bowel syndrome differ - Mayo Clinic News Network

   ... IBD, and irritable bowel syndrome, or IBS ... Inflammatory bowel disease is a group of autoimmune diseases that include ulcerative colitis and Crohn's disease.

10. A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302) - Mayo Clinic

    ... Ulcerative Colitis (FIGARO UC 302). Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More ...